BD Veritor™ System for Rapid Detection of SARS-CoV-2

Time is limited. Results are critical. Staff are busy. Now is when your team needs clear test results, streamlined workflows, efficient documentation and traceability.

The BD Veritor Plus System is designed to address these needs in 15 minutes.

Types of COVID-19 Testing

BD is deploying our capabilities, expertise, and scale to address critical health needs related to the coronavirus—from diagnostic offerings which identify COVID-19 to essential medical devices that support patient care. As the global healthcare community searches for effective methods for addressing COVID-19, the role of testing becomes more prominent. There are currently two kinds of tests available: viral tests and antibody tests.


The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.

As you navigate the ever-changing complexities of COVID-19, it is essential to have tools that minimize uncertainty. The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 is engineered to make testing simple and reliable with results available in 15 minutes¹.

Step 1

Collect patient sample


Step 2

Remove cap & insert swab into tube


Step 3

Mix sample with reagent, then remove swab


Step 4

Close dispensing cap, then dispense sample into test device


Step 5

Insert test device into the analyzer

For Walk Away mode, insert immediately

For Analyze Now mode, insert after processing sample

  1. Step 1
  2. Step 2
  3. Step 3
  4. Step 4
  5. Step 5

BD E-learning Platform Maximizing the capabilities of the BD Veritor™ Plus System


The comprehensive eLearning platform for the BD Veritor™ Plus system streamlines and simplifies training and tracking (local regulation or accreditation efforts), enabling you to quickly train staff and implement point-of-care testing.

Learn more

News & media

Hear from scientist BD leaders

Interview with Dr Patrick R. Murray on C-19 Antigen Tests


Interview with Dr Celine Roger-Dalbert on BD Veritor™ Plus System



WHO supports the use of point of care test

WHO guideline


Learn more about Interim guidance for rapid antigen testing for SARS-CoV-2

US CDC guıdelıne


Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK



Learn more about Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response



Let's have a conversation